ba0001pp159 | Cancer and bone: basic, translational and clinical | ECTS2013
Buckle Clive
, Faraahi Zahra
, Lawson Michelle
, Eaton Colby
, Vanderkerken Karin
, Croucher Peter
Introduction: Patients with multiple myeloma (MM) commonly present with devastating bone disease mediated by increased bone resorption and suppressed bone formation. We have previously shown that blocking activity of the Wnt antagonist Dkk-1 promotes osteoblastogenesis and inhibits development of bone lesions in experimental models of MM. In the 5T murine models of MM, tumour cells home to the bone marrow. Injection of 5T2MM cells into C57BLKalwRij mice results in bone disease...